Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Finerenone 10mg, 20mg Tablets

Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) used for the management of chronic kidney disease (CKD) associated with Type 2 Diabetes Mellitus. It helps reduce kidney function decline and cardiovascular complications in diabetic patients.

Category:
QUICK INQUIRY NOW

Description

Mechanism of Action:

Blocks mineralocorticoid receptors, reducing inflammation and fibrosis in the kidneys.
Slows kidney disease progression in diabetic patients.
Provides cardiovascular benefits by lowering hypertension and fluid retention.

Indications:

Chronic Kidney Disease (CKD) associated with Type 2 Diabetes Mellitus
Cardiovascular risk reduction in diabetic patients

Key Benefits:

Protects kidney function in diabetic patients
Reduces risk of heart failure and cardiovascular events
Helps control hypertension and fluid retention

Dosage & Administration:

  • Recommended Dosage: 10 mg or 20 mg once daily, as prescribed.
  • Route of Administration: Oral
  • Food Intake: Can be taken with or without food.

Precautions & Warnings:

  • Monitor kidney function and potassium levels regularly.
  • Not recommended for patients with severe kidney impairment.
  • Avoid use with strong CYP3A4 inhibitors.

Possible Side Effects:

  • Hyperkalemia (high potassium levels)
  • Hypotension
  • Dizziness

Storage & Packaging:

  • Store below 30°C in a cool, dry place.
  • Available in blister packs and bulk packaging.

Manufacturing & Regulatory Compliance:

Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.

Global Export & Supply:

Aetos Life Care exports Finerenone 10 mg, 20 mg Tablets to Latin America, Africa, Asia, Europe, and CIS countries, providing advanced treatment solutions for diabetic kidney disease worldwide.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar